Rare variants in dynein heavy chain genes in two individuals with situs inversus and developmental dyslexia: a case report.


Journal

BMC medical genetics
ISSN: 1471-2350
Titre abrégé: BMC Med Genet
Pays: England
ID NLM: 100968552

Informations de publication

Date de publication:
01 05 2020
Historique:
received: 17 11 2019
accepted: 05 04 2020
entrez: 3 5 2020
pubmed: 3 5 2020
medline: 17 7 2020
Statut: epublish

Résumé

Developmental dyslexia (DD) is a neurodevelopmental learning disorder with high heritability. A number of candidate susceptibility genes have been identified, some of which are linked to the function of the cilium, an organelle regulating left-right asymmetry development in the embryo. Furthermore, it has been suggested that disrupted left-right asymmetry of the brain may play a role in neurodevelopmental disorders such as DD. However, it is unknown whether there is a common genetic cause to DD and laterality defects or ciliopathies. Here, we studied two individuals with co-occurring situs inversus (SI) and DD using whole genome sequencing to identify genetic variants of importance for DD and SI. Individual 1 had primary ciliary dyskinesia (PCD), a rare, autosomal recessive disorder with oto-sino-pulmonary phenotype and SI. We identified two rare nonsynonymous variants in the dynein axonemal heavy chain 5 gene (DNAH5): a previously reported variant c.7502G > C; p.(R2501P), and a novel variant c.12043 T > G; p.(Y4015D). Both variants are predicted to be damaging. Ultrastructural analysis of the cilia revealed a lack of outer dynein arms and normal inner dynein arms. MRI of the brain revealed no significant abnormalities. Individual 2 had non-syndromic SI and DD. In individual 2, one rare variant (c.9110A > G;p.(H3037R)) in the dynein axonemal heavy chain 11 gene (DNAH11), coding for another component of the outer dynein arm, was identified. We identified the likely genetic cause of SI and PCD in one individual, and a possibly significant heterozygosity in the other, both involving dynein genes. Given the present evidence, it is unclear if the identified variants also predispose to DD and further studies into the association between laterality, ciliopathies and DD are needed.

Sections du résumé

BACKGROUND
Developmental dyslexia (DD) is a neurodevelopmental learning disorder with high heritability. A number of candidate susceptibility genes have been identified, some of which are linked to the function of the cilium, an organelle regulating left-right asymmetry development in the embryo. Furthermore, it has been suggested that disrupted left-right asymmetry of the brain may play a role in neurodevelopmental disorders such as DD. However, it is unknown whether there is a common genetic cause to DD and laterality defects or ciliopathies.
CASE PRESENTATION
Here, we studied two individuals with co-occurring situs inversus (SI) and DD using whole genome sequencing to identify genetic variants of importance for DD and SI. Individual 1 had primary ciliary dyskinesia (PCD), a rare, autosomal recessive disorder with oto-sino-pulmonary phenotype and SI. We identified two rare nonsynonymous variants in the dynein axonemal heavy chain 5 gene (DNAH5): a previously reported variant c.7502G > C; p.(R2501P), and a novel variant c.12043 T > G; p.(Y4015D). Both variants are predicted to be damaging. Ultrastructural analysis of the cilia revealed a lack of outer dynein arms and normal inner dynein arms. MRI of the brain revealed no significant abnormalities. Individual 2 had non-syndromic SI and DD. In individual 2, one rare variant (c.9110A > G;p.(H3037R)) in the dynein axonemal heavy chain 11 gene (DNAH11), coding for another component of the outer dynein arm, was identified.
CONCLUSIONS
We identified the likely genetic cause of SI and PCD in one individual, and a possibly significant heterozygosity in the other, both involving dynein genes. Given the present evidence, it is unclear if the identified variants also predispose to DD and further studies into the association between laterality, ciliopathies and DD are needed.

Identifiants

pubmed: 32357925
doi: 10.1186/s12881-020-01020-2
pii: 10.1186/s12881-020-01020-2
pmc: PMC7193346
doi:

Substances chimiques

Axonemal Dyneins EC 3.6.4.2
DNAH11 protein, human EC 3.6.4.2
DNAH5 protein, human EC 3.6.4.2
Dyneins EC 3.6.4.2

Types de publication

Case Reports Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

87

Références

PLoS One. 2012;7(12):e52166
pubmed: 23300604
Neurosci Biobehav Rev. 2018 Jan;84:434-452
pubmed: 28797557
Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11553-8
pubmed: 12954984
Am J Hum Genet. 2015 Jan 8;96(1):81-92
pubmed: 25557784
Brain Struct Funct. 2018 May;223(4):1937-1952
pubmed: 29302744
Biochem Biophys Res Commun. 2014 Sep 19;452(2):236-43
pubmed: 25078623
Thorax. 2012 May;67(5):433-41
pubmed: 22184204
Neurology. 1999 Oct 12;53(6):1260-5
pubmed: 10522882
Am J Med Genet B Neuropsychiatr Genet. 2009 Jan 5;150B(1):140-7
pubmed: 18521840
Brain Lang. 2017 Nov;174:9-15
pubmed: 28709112
PLoS One. 2012;7(4):e35618
pubmed: 22558177
Hum Mol Genet. 2015 May 1;24(9):2482-91
pubmed: 25601850
Hum Genet. 2015 Nov;134(11-12):1239-48
pubmed: 26400686
J Neurol Neurosurg Psychiatry. 2007 Jan;78(1):5-13
pubmed: 16963501
J Hepatol. 2016 Dec;65(6):1179-1187
pubmed: 27469900
Clin Chest Med. 2016 Sep;37(3):449-61
pubmed: 27514592
J Neurol Sci. 2010 Jan 15;288(1-2):72-8
pubmed: 19897211
Cilia. 2015 Jan 22;4(1):2
pubmed: 25610612
Adv Genet. 2016;96:53-97
pubmed: 27968731
J Med Genet. 2009 Apr;46(4):281-6
pubmed: 19357118
Nat Genet. 2013 Sep;45(9):995-1003
pubmed: 23872636
Hum Brain Mapp. 2014 Dec;35(12):5717-35
pubmed: 25044828
Expert Rev Mol Med. 2015 Jan 27;16:e19
pubmed: 26258520
Hum Mutat. 2016 Oct;37(10):1025-9
pubmed: 27319779
Proc Biol Sci. 2004 Dec 22;271(1557):2579-82
pubmed: 15615683
Neurobiol Dis. 2010 May;38(2):173-80
pubmed: 19616627
Genet Med. 2017 Oct;19(10):1105-1117
pubmed: 28492532
Nature. 2014 Apr 10;508(7495):199-206
pubmed: 24695229
Sci Rep. 2020 Feb 28;10(1):3677
pubmed: 32111882
PLoS One. 2013 May 01;8(5):e63123
pubmed: 23650548
Ann Neurol. 1985 Aug;18(2):222-33
pubmed: 4037763
FASEB J. 2016 Oct;30(10):3578-3587
pubmed: 27451412
PLoS One. 2011;6(6):e20580
pubmed: 21698230
Science. 2016 Jun 10;352(6291):1341-4
pubmed: 27284198
Genes (Basel). 2017 Jan 25;8(2):
pubmed: 28125008
Cortex. 2018 Sep;106:12-25
pubmed: 29864592
Brain. 2000 Dec;123 Pt 12:2512-8
pubmed: 11099452
Am J Respir Crit Care Med. 2006 Jul 15;174(2):120-6
pubmed: 16627867

Auteurs

Andrea Bieder (A)

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Huddinge, Sweden. andrea.bieder@ki.se.

Elisabet Einarsdottir (E)

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Huddinge, Sweden.
Stem Cells and Metabolism Research Program (STEMM), University of Helsinki, Helsinki, Finland.
Folkhälsan Institute of Genetics, Helsinki, Finland.
Science for Life Laboratory, Department of Gene Technology, KTH-Royal Institute of Technology, Solna, Sweden.

Hans Matsson (H)

Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden.
Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Harriet E Nilsson (HE)

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Huddinge, Sweden.
Department of Biomedical Engineering and Health Systems, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH Royal Institute of Technology, Huddinge, Sweden.

Jesper Eisfeldt (J)

Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Science for Life Laboratory, Karolinska Institutet Science Park, Solna, Sweden.

Anca Dragomir (A)

Department of Pathology, Uppsala University Hospital, Uppsala, Sweden.
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Martin Paucar (M)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

Tobias Granberg (T)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Radiology, Karolinska University Hospital, Stockholm, Sweden.

Tie-Qiang Li (TQ)

Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.

Anna Lindstrand (A)

Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Juha Kere (J)

Department of Biosciences and Nutrition, Karolinska Institutet, Hälsovägen 7, 141 83, Huddinge, Sweden.
Stem Cells and Metabolism Research Program (STEMM), University of Helsinki, Helsinki, Finland.
School of Basic and Medical Biosciences, King's College London, Guy's Hospital, London, UK.

Isabel Tapia-Páez (I)

Department of Medicine, Solna, Karolinska Institutet, Solnavägen 30, 171 76 Solna, Stockholm, Sweden. isabel.tapia@ki.se.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH